For research use only. Not for therapeutic Use.
Ligelizumab (QGE 031) is a humanized high-affinity monoclonal anti-IgE antibody. Ligelizumab can be used for the research of chronic spontaneous urticarial[1].
| Catalog Number | I042416 |
| CAS Number | 1322627-61-1 |
| Purity | ≥95% |
| Reference | [1]. Gasser P, et al. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab. Nat Commun. 2020 Jan 8;11(1):165. |
